Work

A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

Year: 2024

Type: article

Study design: Clinical Trial

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2024.2361841

Authors: Geoffrey Shouse, Lu Chen, Tanya Siddiqi, Alex Muir, Jennifer R. Brown, Stephen E. Spurgeon, Alexey V. Danilov

Institutions: City Of Hope National Medical Center, Dana-Farber Cancer Institute, Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399353578

FWCI:

Cites: 13

Cited by:

Related to: 10